With over $2B assets under management, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.
Acerta Pharma Announces Strategic Transaction with AstraZeneca
Frazier Healthcare Partners Creates Hawkeye Therapeutics, Backing Three Serial Entrepreneurs to Acquire Attractive Assets
Tachi Yamada, M.D., Former Head of GSK and Takeda R&D, Re-Joins Frazier Healthcare as Venture Partner
DSI Renal Reaches 100 Dialysis Clinics Milestone